Join Shares Magazine and AJ Bell Media for their next webinar on Tuesday 2 March 2021 which can be accessed from wherever you are!
The webinar will feature:
Diurnal Group (DNL) is a specialty pharmaceutical company developing hormone therapeutics to aid lifelong treatment for rare and chronic endocrine conditions, including Congenital Adrenal Hyperplasia, Adrenal Insufficiency, Hypogonadism and Hypothyroidism.
Frenkel Topping Group (FEN) is engaged in the financial services sector. Its activities include specialist independent financial advice and wealth management with the objective of growing the assets under management.
ReNeuron Group (RENE) is a biotechnology firm. The principal of the business involves the research and development of stem cell technology for the treatment of motor disabilities and blindness-causing diseases.
Go here for further details and to register